These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39190880)
21. Autophagy-related CMTM6 promotes glioblastoma progression by activating Wnt/β-catenin pathway and acts as an onco-immunological biomarker. Dai L; Xiao J; Li X; Tao Y; Zhou P; Lyu L; Shi Z; Liang X; Jia Z; Jiang S J Gene Med; 2024 May; 26(5):e3685. PubMed ID: 38686653 [TBL] [Abstract][Full Text] [Related]
22. AEBP1 Promotes Glioblastoma Progression and Activates the Classical NF- Guo K; Song L; Chang J; Cao P; Liu Q Behav Neurol; 2020; 2020():8890452. PubMed ID: 33224311 [TBL] [Abstract][Full Text] [Related]
23. Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients. Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C DNA Cell Biol; 2019 Jul; 38(7):688-699. PubMed ID: 31188028 [TBL] [Abstract][Full Text] [Related]
24. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis. Yin X; Wu Q; Hao Z; Chen L Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915 [TBL] [Abstract][Full Text] [Related]
25. Comprehensive analysis of lncRNA-associated ceRNA network reveals novel potential prognostic regulatory axes in glioblastoma multiforme. Bazrgar M; Mirmotalebisohi SA; Ahmadi M; Azimi P; Dargahi L; Zali H; Ahmadiani A J Cell Mol Med; 2024 Jun; 28(11):e18392. PubMed ID: 38864705 [TBL] [Abstract][Full Text] [Related]
26. AEBP1 down regulation induced cell death pathway depends on PTEN status of glioma cells. Sinha S; Renganathan A; Nagendra PB; Bhat V; Mathew BS; Rao MRS Sci Rep; 2019 Oct; 9(1):14577. PubMed ID: 31601918 [TBL] [Abstract][Full Text] [Related]
28. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression. Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962 [TBL] [Abstract][Full Text] [Related]
29. A 63 signature genes prediction system is effective for glioblastoma prognosis. Zhang Y; Xu J; Zhu X Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370 [TBL] [Abstract][Full Text] [Related]
30. Identification and verification on prognostic index of glioblastoma immune-related lncRNAs. Zheng G; Jiang Q; Jiang C; Zhu X; Wang Y Adv Clin Exp Med; 2024 Aug; 33(8):843-856. PubMed ID: 38376452 [TBL] [Abstract][Full Text] [Related]
31. Construction and validation of cell cycle-related prognostic genetic model for glioblastoma. Zhou R; Zhang K; Dai T; Guo Z; Li T; Hong X Medicine (Baltimore); 2024 Oct; 103(40):e39205. PubMed ID: 39465756 [TBL] [Abstract][Full Text] [Related]
32. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma. Huang QR; Li JW; Pan XB Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227 [TBL] [Abstract][Full Text] [Related]
33. Identification of Necroptosis-related Molecular Subtypes and Construction of Necroptosis-related Gene Signature for Glioblastoma Multiforme. Li Z; Jin Y; Que T; Zhang XA; Yi G; Zheng H; Yuan X; Wang X; Xu H; Nan J; Chen C; Wu Y; Huang G Curr Med Chem; 2024; 31(33):5417-5431. PubMed ID: 37539935 [TBL] [Abstract][Full Text] [Related]
34. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma. Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538 [TBL] [Abstract][Full Text] [Related]
35. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome. Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797 [TBL] [Abstract][Full Text] [Related]
36. Lysyl oxidase-like 1 predicts the prognosis of patients with primary glioblastoma and promotes tumor invasion Yuan GQ; Zhang G; Nie Q; Wang Z; Gao HZ; Jin GS; Zheng ZQ PeerJ; 2024; 12():e17579. PubMed ID: 38978755 [TBL] [Abstract][Full Text] [Related]
37. Identification of a panel of genes as a prognostic biomarker for glioblastoma. Wang F; Zheng Z; Guan J; Qi D; Zhou S; Shen X; Wang F; Wenkert D; Kirmani B; Solouki T; Fonkem E; Wong ET; Huang JH; Wu E EBioMedicine; 2018 Nov; 37():68-77. PubMed ID: 30341039 [TBL] [Abstract][Full Text] [Related]
38. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network. Cao Y; Wang P; Ning S; Xiao W; Xiao B; Li X Oncotarget; 2016 Jul; 7(27):41737-41747. PubMed ID: 27229531 [TBL] [Abstract][Full Text] [Related]
39. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion. Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832 [TBL] [Abstract][Full Text] [Related]
40. A 4-gene panel predicting the survival of patients with glioblastoma. Guo XX; Su J; He XF J Cell Biochem; 2019 Sep; 120(9):16037-16043. PubMed ID: 31081973 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]